Subject to confirmation in larger trials, these differences in darbepoetin alfa dosing requirements might make intravenous administration more cost-efficient than the subcutaneous route.

You have full access to this article via your institution. Although the intramuscular route is commonly used for administering human vaccines, subcutaneous, intraperitoneal and intramuscular ...

Materials & methods: The safety of subcutaneous immunotherapy (SCIT), administered by means of a 4-week cluster titration schedule (cluster-SCIT) or by an 8-week short conventional titration ...

In order to minimize such reactions, the subcutaneous route has been proposed. Whereas subcutaneous alemtuzumab has already been used in hematological diseases, up to now, there is no evidence of ...

Dr Marjorie Green, head of global clinical development, oncology, at Merck Research Labs, said the subcutaneous route "has the potential to improve the patient experience as well as increase ...

Subcutaneous immunotherapy injections work the same way as their intravenous counterparts — by changing or enhancing a person’s immune responses to cancer. Immunotherapy for cancer is a broad ...

This article explores types of immunotherapy for upper GI cancer, how subcutaneous immunotherapy injections work, and considerations for when a doctor may add these types of therapies to a cancer ...

Subcutaneous fat is stored just beneath the skin and can be pinched with your fingers. Visceral fat lies deep within the abdominal walls and surrounds the organs. Visceral fat tends to cause bad ...

Subcutaneous Opdivo showed similar efficacy and safety to intravenous Opdivo in advanced ccRCC, with a slightly higher overall response rate. The CheckMate-67T trial confirmed pharmacokinetic and ...

Bristol-Myers Squibb is getting closer to offering a subcutaneous version of its cancer immunotherapy Opdivo to patients after it matched the current intravenous formulation in a head-to-head ...

formulation associated with a new route of administration (subcutaneous use), a new pharmaceutical form (solution for injection) and a new strength (600 mg/vial). Nivolumab for subcutaneous use co ...

Merck MRK announced that the FDA has accepted its regulatory filing seeking approval for the subcutaneous (under the skin or SC) formulation of the blockbuster drug Keytruda (pembrolizumab).